Olmesartan Medoxomil/Amlodipine Maleate

奥美沙坦酯/马来酸氨氯地平

Report date: 2022/08/09 18:06:03

Base Information

Drug NameOlmesartan Medoxomil/Amlodipine Maleate
Drug Alias NameOlmesartan Medoxomil+Amlodipine Maleate奥美沙坦酯+马来酸氨氯地平马来酸氨氯地平+奥美沙坦酯Amlodipine Maleate/Olmesartan Medoxomil马来酸氨氯地平/奥美沙坦酯 +[7] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2014/12/01
Country/TerritorySouth Korea
CombinationsYes Olmesartan MedoxomilAmlodipine Maleate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaewon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB02
Related LinksN/A